In a patient who has developed bradycardia, is it appropriate to give a half tablet (1 mg) of perampanel?

Do Not Give Half Tablet of Perampanel for Bradycardia

Stop perampanel entirely if bradycardia has developed—do not attempt dose reduction to half a tablet. Bradycardia is a recognized adverse effect of perampanel that requires discontinuation or at minimum complete temporary cessation, not dose adjustment 1.

Why Dose Reduction Is Not Appropriate

Perampanel's Pharmacokinetic Profile Makes Dose Adjustment Impractical

• Extremely long half-life of 105 hours means steady-state takes 2-3 weeks to achieve 1
• Any dose change (including halving the dose) will take weeks to reflect in plasma concentrations
• The bradycardia you're seeing now is from drug already in the system—reducing today's dose won't help today's problem
• Even after complete discontinuation, perampanel effects persist for days to weeks due to this prolonged elimination 2, 3

Bradycardia Is a Serious Adverse Effect Requiring Action

Perampanel overdose and toxicity cases consistently demonstrate:

• Bradycardia occurs as part of the toxicity profile 2, 3, 4
• Cardiovascular effects including hypotension and bradycardia can be severe and prolonged 3, 4
• In pediatric cases, bradycardia persisted for 32+ hours and required fluid resuscitation 3
• These cardiovascular effects are attributed directly to perampanel toxicity 3

Immediate Management of Bradycardia

First-Line Treatment (Not Perampanel Adjustment)

If the patient has symptomatic bradycardia (heart rate <50 bpm with signs of hypoperfusion):

1. Atropine 1.0 mg IV is the preferred initial dose (superior to 0.5 mg with 44.8% vs 25.3% first-dose success) 5

   • Can repeat every 5 minutes up to maximum 2 mg total 6, 7
   • Doses <0.5 mg may paradoxically worsen bradycardia 7, 8

2. Transcutaneous pacing should be readily available 6, 9

3. If atropine fails: Consider dopamine 2-20 mcg/kg/min or other chronotropic support 6, 10

Address the Root Cause

The bradycardia is medication-induced—perampanel must be stopped 9, 8:

• Guideline consensus: patients with symptomatic bradycardia secondary to medications should have the offending drug eliminated 9
• Beta-blockers and calcium channel blockers are commonly cited, but any negative chronotropic drug (including perampanel) follows the same principle 11, 9

Common Pitfalls to Avoid

1. Don't wait to see if half-dose helps—the 105-hour half-life means you're managing accumulated drug, not today's dose
2. Don't assume bradycardia will self-resolve—perampanel toxicity cases show prolonged cardiovascular effects requiring active management 2, 3
3. Don't give atropine <0.5 mg—paradoxical worsening can occur 7, 8
4. Don't forget supportive care—patients may need prolonged monitoring given perampanel's extended half-life 2, 3

What Happens After Stopping Perampanel

• Expect gradual improvement over days to weeks as drug clears 1, 2
• Monitor for other perampanel toxicity manifestations: CNS depression, ataxia, behavioral changes 2, 3, 4
• Consider phenobarbital if seizure prophylaxis needed during the washout period (also may enhance perampanel metabolism) 2
• No reversal agent exists for perampanel 2

Bottom line: Bradycardia from perampanel requires stopping the drug and treating the bradycardia directly with atropine/pacing, not attempting dose reduction.